Novel Immunotherapy approaches to engaging the Innate Immune System

from Rx for Biotech · host Podcast Host Chris Leidli

In this podcast episode, Dr. Michael Alonso, VP of Immunology and Pharmacology at Bolt Biotherapeutics, discusses how the company is developing cancer therapies that engage the innate immune system to generate robust anti-tumor responses.

Episode metadata supplied by the publisher feed · Published Jul 6, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Novel Immunotherapy approaches to engaging the Innate Immune System

0:00 15:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 15 minutes long.

When was this Rx for Biotech episode published?

This episode was published on July 6, 2023.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!